1. Home
  2. PRGO vs ICUI Comparison

PRGO vs ICUI Comparison

Compare PRGO & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRGO
  • ICUI
  • Stock Information
  • Founded
  • PRGO 1887
  • ICUI 1984
  • Country
  • PRGO Ireland
  • ICUI United States
  • Employees
  • PRGO N/A
  • ICUI N/A
  • Industry
  • PRGO Biotechnology: Pharmaceutical Preparations
  • ICUI Medical/Dental Instruments
  • Sector
  • PRGO Health Care
  • ICUI Health Care
  • Exchange
  • PRGO Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • PRGO 3.7B
  • ICUI 3.4B
  • IPO Year
  • PRGO 1991
  • ICUI 1992
  • Fundamental
  • Price
  • PRGO $27.51
  • ICUI $125.47
  • Analyst Decision
  • PRGO Buy
  • ICUI Strong Buy
  • Analyst Count
  • PRGO 3
  • ICUI 5
  • Target Price
  • PRGO $33.00
  • ICUI $196.75
  • AVG Volume (30 Days)
  • PRGO 865.0K
  • ICUI 170.4K
  • Earning Date
  • PRGO 08-06-2025
  • ICUI 08-07-2025
  • Dividend Yield
  • PRGO 4.15%
  • ICUI N/A
  • EPS Growth
  • PRGO N/A
  • ICUI N/A
  • EPS
  • PRGO N/A
  • ICUI N/A
  • Revenue
  • PRGO $4,335,200,000.00
  • ICUI $2,420,093,000.00
  • Revenue This Year
  • PRGO $3.35
  • ICUI N/A
  • Revenue Next Year
  • PRGO $2.17
  • ICUI N/A
  • P/E Ratio
  • PRGO N/A
  • ICUI N/A
  • Revenue Growth
  • PRGO N/A
  • ICUI 7.22
  • 52 Week Low
  • PRGO $23.14
  • ICUI $117.92
  • 52 Week High
  • PRGO $30.93
  • ICUI $196.26
  • Technical
  • Relative Strength Index (RSI)
  • PRGO 52.09
  • ICUI 42.58
  • Support Level
  • PRGO $26.84
  • ICUI $121.38
  • Resistance Level
  • PRGO $28.44
  • ICUI $130.37
  • Average True Range (ATR)
  • PRGO 0.56
  • ICUI 3.27
  • MACD
  • PRGO 0.04
  • ICUI -0.00
  • Stochastic Oscillator
  • PRGO 48.62
  • ICUI 27.99

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: